| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2328091-01-4 | tert-Butyl (7-bromopyrrolo[2,1-f][1,2,4]triazin-4-yl)carbamate | C11H13BrN4O2 |
| 2330770-71-1 | 9-Bromo-10-(naphthalen-1-yl)anthracene-1,2,3,4,5,6,7,8-d8 | C24H7D8Br |
| 2331211-57-3 | (1S,3R)-3-Amino-cyclohexanol hydrochloride | C6H14ClNO |
| 2332724-21-5 | Itopride Impurity 1 | C25H25NO7 |
| 2332841-25-3 | TBAJ-876 | C31H37BrN4O7 |
| 2338845-31-9 | Parecoxib Impurity 18 | C32H24N2O4S |
| 2344681-17-8 | Tert-butyl 2,2-dioxo-2lambda6-thia-3,8-diazaspiro[4.5]decane-8-carboxylate | C12H22N2O4S |
| 2344685-75-0 | 8-Oxa-2-thia-3-azaspiro[4.5]decane 2,2-dioxide | C7H13NO3S |
| 2346620-55-9 | 2',3'-O-(1-methylethylidene)-Uridine 4-oxime 5'-(2-methylpropanoate) | C16H23N3O7 |
| 2348441-63-2 | Aprepitant EP Impurity C | C29H25F7N4O3 |
| 2349358-81-0 | 1-Propionyl-lysergic acid diethylamide | C23H29N3O2 |
| 2349386-89-4 | Molnupiravir | C13H19N3O7 |
| 2351918-80-2 | 7-Bromo-2-chlorodibenzofuran | C12H6BrClO |
| 2355229-03-5 | 2-Bromo-7-chlorodibenzo[b,d]furan | C12H6BrClO |
| 2356153-95-0 | Celecoxib Impurity 5 | C17H14F3N3O3S |
| 2357109-89-6 | 3-Hydroxy-1-(4-methoxybenzyl)piperidine-2,6-dione | C13H15NO4 |
| 2359663-72-0 | Ethyl 5-chloro-6-methoxypyrazolo[1,5-a]pyrimidine-3-carboxylate | C10H10ClN3O3 |
| 2360518-94-9 | 3-[2,3-Dihydro-4-(4-hydroxy-1-butyn-1-yl)-3-methyl-2-oxo-1H-benzimidazol-1-yl]-2,6-piperidinedione | C17H17N3O4 |
| 2360830-97-1 | 7-Chloro-1-phenyldibenzo[b,d]furan | C18H11ClO |
| 2360931-42-4 | 3,3-Dimethoxycyclobutanecarboxamide | C7H13NO3 |
| 2361297-58-5 | 7-(4H-1,3-dioxin-2-yl)-8-hydroxy-9-methoxy-3-methyl-4H-chromeno[3,4-c]pyridin-5-one | C18H17NO6 |
| 2361608-82-2 | (4aS,8aR)-Hexahydro-2H-pyrido[4,3-b][1,4]oxazin-3(4H)-one hydrochloride | 192.643 Da |
| 2361613-60-5 | 2-{4-Bromo-1-[5-(2-methyl-2-propanyl)-2-biphenylyl]-1H-benzimidazol-2-yl}-4,6-bis(2-methyl-2-propanyl)phenol | C37H41BrN2O |
| 2363172-64-7 | Palbociclib Impurity 39 | C20H22N6O2 |
| 2363753-29-9 | Bortezomib Impurity 32 | C15H28BNO2 .C2HF3O2 |
| 2365342-47-6 | dimethyl((5-methylpyridin-3-yl)imino)-lambda6-sulfanone | C8H12N2OS |
| 2365474-05-9 | Nicorandil Trimer | C24H27N7O6 |
| 2366209-87-0 | 7-(4-Chlorophenyl)-1-phenylnaphthalene | C22H15Cl |
| 2366209-97-2 | 6-Bromo-1-phenylnaphthalene | C16H11Br |
| 2366210-03-7 | 2-(4-Chlorophenyl)-1-phenylnaphthalene | C22H15Cl |
| 2366274-27-1 | Folic Acid EP Impurity H | C31H31N9O10 |
| 2369979-68-8 | JHU37160 (DREADD ligand) | C19H20ClFN4 |
| 2375259-86-0 | (5,5-Dimethyl-3-pyrrolidinyl)acetic acid hydrochloride | C8H16ClNO2 |
| 2375281-44-8 | NF-kappaBeta activator 2 | C16H11FN2O3 |
| 2375281-56-2 | 3-[2-[(2-fluorophenyl)amino]-5-oxazolyl]-Benzoic acid methyl ester | C17H13N2O3F |
| 2375421-09-1 | SR-717 lithium | C15H8F2LiN5O3 |
| 2375865-91-9 | Rosuvastatin Impurity 18 | C15H26O6 |
| 2376271-49-5 | Tetratetraconta-4,17,21,27,40-pentaen-1,12,15,43-tetrayne-3,6,11,14,42-pentol | C44H64O5 |
| 2376271-61-1 | N-[7-[(Z)-1-(3-ethenyl-7-phenyl-1H-indol-2-yl)prop-1-enyl]-9H-fluoren-2-yl]-10-methyl-N-(4-phenylphenyl)-9,10-dihydrophenanthren-2-amine | C59H44N2 |
| 2376607-99-5 | Sugammadex Monohydroxy Impurity (7Na salt) | C69H101Na7O47S7 |
| 2376668-89-0 | Atomoxetine Impurity 8 | C18H21NO2 |
| 2376990-29-1 | Thalidomide-O-C4-NH2 (hydrochloride) | C17H20ClN3O5 |
| 2377545-66-7 | 9-Bromo-10-phenylanthracene-1,2,3,4,5,6,7,8-d8 | C20H5D8Br |
| 2377545-67-8 | 9-([1,1'-biphenyl]-4-yl)-10-bromoanthracene-1,2,3,4,5,6,7,8-d8 | C26H9D8Br |
| 2377545-68-9 | 9-Bromo-10-(phenyl-d5)anthracene-1,2,3,4,5,6,7,8-d8 | C20D13Br |
| 2377645-90-2 | 4-Chloro-3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzoic acid | C11H9ClN2O4 |
| 2377770-18-6 | (2-(3,6-Dimethoxy-9H-carbazol-9-yl)ethyl)phosphonic acid | C16H18NO5P |
| 2378104-61-9 | 4-(5,6-dimethoxythieno[2,3-b]pyridin-2-yl)-4-oxobutanoic acid | C13H13NO5S |
| 2378104-86-8 | 2-Bromo-5.6-dimethoxynicotinaldehyde | C8H8BrNO3 |
| 2378356-17-1 | 2'-(9H-Carbazol-9-yl)-[1,1'-biphenyl]-4-amine | C24H18N2 |